Medicare Enrolled

Dr. Maria Dominique Mortel-Gabro, M.D.

Neurology · Albany, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2709 MEREDYTH DR STE 340, Albany, GA 31707
2293125733
In practice since 2017 (9 years)
NPI: 1447783592 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mortel-Gabro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mortel-Gabro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mortel-Gabro

Dr. Maria Dominique Mortel-Gabro is a neurology specialist in Albany, GA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Mortel-Gabro performed 87 Medicare services across 84 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mortel-Gabro received a total of $4,132 from 33 pharmaceutical and/or device companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mortel-Gabro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ 87 Medicare services $4,132 industry payments

Medicare Practice Summary

Medicare Utilization ↗
87
Medicare services
Bottom 11% in GA for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
84
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
 26 $125 $255
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
 17 $93 $260
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 16 $86 $182
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 15 $67 $129
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
 13 $77 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,132
Total received (2018-2024)
Avg $689/year across 6 years
Top 40% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
146
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,132 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,475
2023
$882
2022
$302
2021
$132
2019
$180
2018
$161

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$659
Neurocrine Biosciences, Inc.
$321
ABBVIE INC.
$155
Neurelis, Inc.
$149
UCB, Inc.
$130
SK Life Science, Inc.
$121
Novartis Pharmaceuticals Corporation
$118
Biogen, Inc.
$111
Alexion Pharmaceuticals, Inc.
$111
PFIZER INC.
$108
ARGENX US, INC.
$78
E.R. Squibb & Sons, L.L.C.
$73
Sumitomo Pharma America, Inc.
$57
Lilly USA, LLC
$53
Eisai Inc.
$50
Lundbeck LLC
$41
TG Therapeutics, Inc.
$38
Genentech USA, Inc.
$29
CATALYST PHARMACEUTICALS, INC.
$26
Grifols USA, LLC
$24
SCILEX PHARMACEUTICALS INC.
$21
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$659
Neurocrine Biosciences, Inc.
$321
NEUROPACE, INC.
$302
ABBVIE INC.
$290
Biogen, Inc.
$272
Neurelis, Inc.
$219
PFIZER INC.
$200
Alexion Pharmaceuticals, Inc.
$191
SK Life Science, Inc.
$173
Novartis Pharmaceuticals Corporation
$159
UCB, Inc.
$153
AbbVie Inc.
$132
Teva Pharmaceuticals USA, Inc.
$104
Lilly USA, LLC
$87
Catalyst Pharmaceuticals, Inc.
$82
ARGENX US, INC.
$78
Sumitomo Pharma America, Inc.
$78
E.R. Squibb & Sons, L.L.C.
$73
Lundbeck LLC
$71
Otsuka America Pharmaceutical, Inc.
$66
Eisai Inc.
$64
Genentech USA, Inc.
$52
Mallinckrodt LLC
$51
Medtronic, Inc.
$43
TG Therapeutics, Inc.
$38
CATALYST PHARMACEUTICALS, INC.
$26
Corium, LLC
$25
Grifols USA, LLC
$24
Mallinckrodt Enterprises LLC
$23
SCILEX PHARMACEUTICALS INC.
$21
AstraZeneca Pharmaceuticals LP
$20
Greenwich Biosciences, Inc.
$19
IMPEL PHARMACEUTICALS INC.
$16
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA PC · AMYVID · APTIOM · AUSTEDO · Adlarity · BOTOX · BRIUMVI · Briviact · DUOPA · EVUSHELD · Epidiolex · Evrysdi · FYCOMPA · Gamunex-C · INGREZZA · KESIMPTA · KISUNLA · Leqembi · NUEDEXTA · NURTEC ODT · Ocrevus · Ocrevus Zunovo · PLEGRIDY · QULIPTA · RNS Neurostimulator Kit · Rystiggo · TECFIDERA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Albany?
Compare neurologists in the Albany area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
5
Per 100K population
6.0
County median income
$46,784
Nearest hospital
PHOEBE WORTH MEDICAL CENTER
18.8 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mortel-Gabro is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mortel-Gabro experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Mortel-Gabro performed 26 new patient office visit (45-59 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mortel-Gabro receive payments from pharmaceutical companies?
Yes. Dr. Mortel-Gabro received a total of $4,132 from 33 companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mortel-Gabro's costs compare to other neurologists in Albany?
Dr. Mortel-Gabro's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mortel-Gabro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Albany
Browse neurologists in Albany ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
NEUROPACE, INC. Payments to Doctors
See all physicians who received payments from NEUROPACE, INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →